CABA
Pharmaceuticals, Biotechnology & Life Sciences
CROWD: GREEN
Quiet institutional ownership. No unusual crowd behavior in the latest filings.
Active holders
44
of 108 total, index funds excluded
Streak
2q
consecutive rising quarters
The crowd, 2016 to now
active holders per quarter
2019Mar 2026
Holdings as of Mar 31, 2026, filed by May 16, 2026. Counts for the newest quarter keep settling for a few weeks as amendments land.
The tide
funds in (up) vs out (down)
Top holders
by reported value · $228M held
| Fund | Value | Note |
|---|
| T. Rowe Price Investment Ma… |
$30M |
|
| Bain Capital Life Sciences … |
$26M |
|
| JENNISON ASSOCIATES LLC |
$24M |
|
| ADAGE CAPITAL PARTNERS GP, … |
$24M |
|
| MILLENNIUM MANAGEMENT LLC |
$16M |
|
| Cormorant Asset Management,… |
$15M |
|
| VANGUARD CAPITAL MANAGEMENT… |
$11M |
|
| TWO SIGMA INVESTMENTS, LP |
$7M |
|
| BlackRock, Inc. |
$6M |
|
| MARSHALL WACE, LLP |
$6M |
|
Tourists vs true believers
every holder a dot · right = bigger bet in their own book, up = patient money
Hover any dot for the fund and its bet size. Patience is measured from each filer's actual quarter-to-quarter turnover across our whole database.